RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Joseph Gibbons to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Joseph Gibbons has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Joseph Gibbons
Connection Strength
0.220
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Milojkovic D, Reynolds CJ, Sandoval DM, Pieper FP, Liu S, Pade C, Gibbons JM, McKnight ?, Loaiza S, Palanicawander R, Innes AJ, Claudiani S, Apperley JF, Altmann DM, Boyton RJ. COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Leukemia. 2023 01; 37(1):244-247.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support